Atlas Trials

Dexamethasone in Refractory or First Relapsed Acute Myeloid Leukemia

Clinical trial NCT03765541 · TERMINATED

Trial details

NCT number
NCT03765541
Sponsor
University Hospital, Toulouse
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Relapsed or Refractory Acute Myeloid Leukemia
Start date
2020-01-13
Primary completion
2024-05-31
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.